Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.
Latus Bio develops innovative gene therapy candidates utilizing precision delivery systems to enhance patient outcomes, particularly in treating CNS diseases. Their proprietary AAV capsids are designed to improve targeting and reduce side effects, aiming for a transformative impact on conditions like Huntington's Disease and genetic hearing loss. With a focus on minimizing toxicity and optimizing administration, Latus is positioned to advance the standard of care in gene therapy, backed by a team of industry-leading scientists and clinicians.
Something looks off?